Blog

Recent findings from a National Multiple Sclerosis (MS) Study estimate that nearly 1 million people in the US are living with MS, a number that has more than doubled since it was last reported in 1975. We at VeraSci are committed to helping our clients drive therapies...

March 8th was International Women’s Day, a day that we at VeraSci celebrate the work of a group of remarkable women – women scientists. While Marie Curie usually dominates the women in science conversation, there are many other brilliant women scientists. Not only did...

VeraSci attended the 6th Annual Diversity Alliance for Science West Coast Conference, February 20th-21st in Laguna Beach, California. VeraSci is honored to participate in one of the leading organizations in the life science and healthcare industries which promotes the...

Clinical drug trials in preclinical AD populations require novel approaches to participant identification, screening, and enrollment. Execution of these trials requires rapid development of cognitive screening instruments that are straightforward, sensitive to...

Clinical trials in mild to moderate Alzheimer’s Disease (AD) rely on informant reports to characterize study participants’ performance on basic and instrumental activities of daily living.  As clinical trials move earlier in the AD continuum, however, these...

Welcome to the third and final installment of our three-part blog series highlighting the importance of choosing the right language services partner. Cultural Adaptation and Localization Cultural adaptation and localization of clinical trial translations can be...

Welcome to the second installment of our three-part blog series highlighting the importance of choosing the right language services partner.   Interpretation Interpretation goes beyond the word-for-word translation of a spoken or written message. Sentence...

In the sharing spirit of the season, VeraSci is presenting a three-part blog series to use as a guide when selecting your language services partner. With the enormous investments and challenging timelines required for bringing new therapies to market, choosing the...

VeraSci attended CNS Summit in Boca Raton, Florida, November 1-4, 2018. CNS Summit is a platform for change in a community passionate about shaping the future through collaboration, innovation, and technology. This year’s conference proved to be a dynamic environment...